Therefore, we evaluated the impact of a peptide fraction from TBSH on the activity of DPP-IV in vitro, assessed the hypoglycemic impact of TBP by elucidating the hyperglycemia-associated characteristics of rats with T2DM, and determined the variations in the gut microbiota and their metabolites. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.